TrialScientific reports2019

Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients.

Max Hardy-Werbin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.